Skip to main content
Equibles
EDIT logo

EDIT · Editas Medicine, Inc.

Track EDIT — free

Use EDIT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.23 +0.15 (+4.87%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$496.06M
Shares
153.58M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

EDIT Latest Reported Short Interest

FINRA reported 24,686,466 EDIT shares sold short as of the August 14, 2026 settlement date, an increase of 1,222,247 shares. Days to cover was 14.59 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

EDIT Short Interest Forecast

Equibles' model estimates 25,154,869 shares sold short for the August 31, 2026 settlement, +1.9% versus the latest reported position, with a likely range of 22,826,055 to 27,318,998 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 Low confidence 47% chance it rises
25,154,869 +1.9% vs reported
Likely range 22,826,055 to 27,318,998 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
81/100
Short interest 16.1% of shares — P96 Days to cover 14.6 — P94 Price vs VWAP +8.1% — P78 Short-volume trend +7.7% — P76 Short interest change +5.2% — P69 Worst FTD 0.00% of shares — P28

Positioning score 80.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-06 09:14 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 24,686,466 23,464,219 +1,222,247 14.59
    2026-07-31 23,464,219 22,197,638 +1,266,581 18.19
    2026-07-15 22,197,638 22,473,029 -275,391 8.02
    2026-06-30 22,473,029 18,414,894 +4,058,135 7.21
    2026-06-15 18,414,894 15,066,130 +3,348,764 7.70
    2026-05-29 15,066,130 9,561,026 +5,505,104 3.36
    2026-05-15 9,561,026 10,007,345 -446,319 8.56
    2026-04-30 10,007,345 10,915,607 -908,262 7.07
    2026-04-15 10,915,607 11,941,373 -1,025,766 6.48
    2026-03-31 11,941,373 11,522,947 +418,426 8.62
    2026-03-13 11,522,947 11,890,283 -367,336 5.07
    2026-02-27 11,890,283 11,747,144 +143,139 8.20
    2026-02-13 11,747,144 11,464,526 +282,618 7.99
    2026-01-30 11,464,526 11,829,004 -364,478 6.11
    2026-01-15 11,829,004 11,320,572 +508,432 6.04
    2025-12-31 11,320,572 11,154,083 +166,489 6.50
    2025-12-15 11,154,083 10,568,381 +585,702 6.36
    2025-11-28 10,568,381 10,005,943 +562,438 7.88
    2025-11-14 10,005,943 8,665,653 +1,340,290 4.99
    2025-10-31 8,665,653 7,619,416 +1,046,237 2.97
    2025-10-15 7,619,416 7,456,270 +163,146 2.17
    2025-09-30 7,456,270 7,561,998 -105,728 2.36
    2025-09-15 7,561,998 7,815,797 -253,799 5.44

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1650664 CUSIP 28106W103 13F (30d) 152 filings 152 filers Visit website Investor relations